Levetiracetam is an effective add-on therapy for refractory partial-onset epilepsy when assessed by seizure-free days

By  

Inpharma, Vol. 1, Iss. 1418, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Add-on levetiracetam beneficial in poorly controlled epilepsy

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 279, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Potential Use of Modulators of Oxidative Stress as Add-on Therapy in Patients with Anxiety Disorders

By  

Current Drug Targets, Vol. 19, Iss. 6, 2018-04 ,pp. : 636-650

Bentham Science Publishers

Access to resources Recommend Favorite

Lifetime Cost-Utility Analysis of Patients with Refractory Epilepsy Treated with Adjunctive Topiramate Therapy: Cost-Effectiveness in Refractory Epilepsy

By Maltoni S.   Messori A.  

Clinical Drug Investigation, Vol. 23, Iss. 4, 2003-01 ,pp. : 225-232

Adis International

Access to resources Recommend Favorite

Levetiracetam safety profiles and tolerability in epilepsy patients

By Briggs Deborah E   French Jacqueline A  

Expert Opinion on Drug Safety, Vol. 3, Iss. 5, 2004-09 ,pp. : 415-424

Informa Healthcare

Access to resources Recommend Favorite